In Vivo Selectivity and Localization of Reactive Oxygen Species (ROS) Induction by Osmium Anticancer Complexes That Circumvent Platinum Resistance
Platinum drugs are widely used for cancer treatment. Other precious metals are promising, but their clinical progress depends on achieving different mechanisms of action to overcome Pt-resistance. Here, we evaluate 13 organo-Os complexes: 16-electron sulfonyl-diamine catalysts [(η6-arene)Os(N,N′)]...
Gespeichert in:
Veröffentlicht in: | Journal of medicinal chemistry 2018-10, Vol.61 (20), p.9246-9255 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 9255 |
---|---|
container_issue | 20 |
container_start_page | 9246 |
container_title | Journal of medicinal chemistry |
container_volume | 61 |
creator | Coverdale, James P. C Bridgewater, Hannah E Song, Ji-Inn Smith, Nichola A Barry, Nicolas P. E Bagley, Ian Sadler, Peter J Romero-Canelón, Isolda |
description | Platinum drugs are widely used for cancer treatment. Other precious metals are promising, but their clinical progress depends on achieving different mechanisms of action to overcome Pt-resistance. Here, we evaluate 13 organo-Os complexes: 16-electron sulfonyl-diamine catalysts [(η6-arene)Os(N,N′)], and 18-electron phenylazopyridine complexes [(η6-arene)Os(N,N’)Cl/I]+ (arene = p-cymene, biphenyl, or terphenyl). Their antiproliferative activity does not depend on p21 or p53 status, unlike cisplatin, and their selective potency toward cancer cells involves the generation of reactive oxygen species. Evidence of such a mechanism of action has been found both in vitro and in vivo. This work appears to provide the first study of osmium complexes in the zebrafish model, which has been shown to closely model toxicity in humans. A fluorescent osmium complex, derived from a lead compound, was employed to confirm internalization of the complex, visualize in vivo distribution, and confirm colocalization with reactive oxygen species generated in zebrafish. |
doi_str_mv | 10.1021/acs.jmedchem.8b00958 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6204601</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2116847286</sourcerecordid><originalsourceid>FETCH-LOGICAL-a449t-6708e1345070bc730eff603ca933c4a0cda8b37f09951ecfad53f17b65786eb03</originalsourceid><addsrcrecordid>eNp9kU9vEzEQxS1ERUPhGyDkYzlsGNv794JURRQiRUqVFK6W1zvbuNq1w9obNf0YfGKcJq3gwmkO83tvRu8R8oHBlAFnn5X20_seG73BflrWAFVWviITlnFI0hLS12QCwHnCcy7OyVvv7wFAMC7ekHMBXEDJiwn5Pbf0p9k5usYOdTA7E_ZU2YYunFadeVTBOEtdS1eoDmuky4f9HVq63qI26Onlarn-ROe2GfUTWu_p0vdm7OmVDUYrq3GgM9dvO3yI-O1GBTozgx77HdpAb7p4wUZ6hd74cMDfkbNWdR7fn-YF-XH99Xb2PVksv81nV4tEpWkVkryAEplIMyig1oUAbNschFaVEDpVoBtV1qJooaoyhrpVTSZaVtR5VpQ51iAuyJej73asDznGdwbVye1gejXspVNG_ruxZiPv3E7mHNIcWDS4PBkM7teIPsjeeI1dpyy60UvOWF6mBS_ziKZHVA_O-wHblzMM5KFOGeuUz3XKU51R9vHvF19Ez_1FAI7Ak9yNg42J_d_zD1mbsrs</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2116847286</pqid></control><display><type>article</type><title>In Vivo Selectivity and Localization of Reactive Oxygen Species (ROS) Induction by Osmium Anticancer Complexes That Circumvent Platinum Resistance</title><source>MEDLINE</source><source>American Chemical Society Journals</source><creator>Coverdale, James P. C ; Bridgewater, Hannah E ; Song, Ji-Inn ; Smith, Nichola A ; Barry, Nicolas P. E ; Bagley, Ian ; Sadler, Peter J ; Romero-Canelón, Isolda</creator><creatorcontrib>Coverdale, James P. C ; Bridgewater, Hannah E ; Song, Ji-Inn ; Smith, Nichola A ; Barry, Nicolas P. E ; Bagley, Ian ; Sadler, Peter J ; Romero-Canelón, Isolda</creatorcontrib><description>Platinum drugs are widely used for cancer treatment. Other precious metals are promising, but their clinical progress depends on achieving different mechanisms of action to overcome Pt-resistance. Here, we evaluate 13 organo-Os complexes: 16-electron sulfonyl-diamine catalysts [(η6-arene)Os(N,N′)], and 18-electron phenylazopyridine complexes [(η6-arene)Os(N,N’)Cl/I]+ (arene = p-cymene, biphenyl, or terphenyl). Their antiproliferative activity does not depend on p21 or p53 status, unlike cisplatin, and their selective potency toward cancer cells involves the generation of reactive oxygen species. Evidence of such a mechanism of action has been found both in vitro and in vivo. This work appears to provide the first study of osmium complexes in the zebrafish model, which has been shown to closely model toxicity in humans. A fluorescent osmium complex, derived from a lead compound, was employed to confirm internalization of the complex, visualize in vivo distribution, and confirm colocalization with reactive oxygen species generated in zebrafish.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/acs.jmedchem.8b00958</identifier><identifier>PMID: 30230827</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Antineoplastic Agents - chemistry ; Antineoplastic Agents - pharmacology ; Cell Line, Tumor ; Cell Proliferation - drug effects ; Drug Resistance, Neoplasm - drug effects ; Drug Screening Assays, Antitumor ; Humans ; Organometallic Compounds - chemistry ; Organometallic Compounds - pharmacology ; Osmium - chemistry ; Platinum - pharmacology ; Reactive Oxygen Species - metabolism</subject><ispartof>Journal of medicinal chemistry, 2018-10, Vol.61 (20), p.9246-9255</ispartof><rights>Copyright © 2018 American Chemical Society 2018 American Chemical Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a449t-6708e1345070bc730eff603ca933c4a0cda8b37f09951ecfad53f17b65786eb03</citedby><cites>FETCH-LOGICAL-a449t-6708e1345070bc730eff603ca933c4a0cda8b37f09951ecfad53f17b65786eb03</cites><orcidid>0000-0001-9160-1941 ; 0000-0003-3847-4626 ; 0000-0002-7779-6620 ; 0000-0002-0388-6295</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.8b00958$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00958$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>230,314,776,780,881,2752,27053,27901,27902,56713,56763</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30230827$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Coverdale, James P. C</creatorcontrib><creatorcontrib>Bridgewater, Hannah E</creatorcontrib><creatorcontrib>Song, Ji-Inn</creatorcontrib><creatorcontrib>Smith, Nichola A</creatorcontrib><creatorcontrib>Barry, Nicolas P. E</creatorcontrib><creatorcontrib>Bagley, Ian</creatorcontrib><creatorcontrib>Sadler, Peter J</creatorcontrib><creatorcontrib>Romero-Canelón, Isolda</creatorcontrib><title>In Vivo Selectivity and Localization of Reactive Oxygen Species (ROS) Induction by Osmium Anticancer Complexes That Circumvent Platinum Resistance</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>Platinum drugs are widely used for cancer treatment. Other precious metals are promising, but their clinical progress depends on achieving different mechanisms of action to overcome Pt-resistance. Here, we evaluate 13 organo-Os complexes: 16-electron sulfonyl-diamine catalysts [(η6-arene)Os(N,N′)], and 18-electron phenylazopyridine complexes [(η6-arene)Os(N,N’)Cl/I]+ (arene = p-cymene, biphenyl, or terphenyl). Their antiproliferative activity does not depend on p21 or p53 status, unlike cisplatin, and their selective potency toward cancer cells involves the generation of reactive oxygen species. Evidence of such a mechanism of action has been found both in vitro and in vivo. This work appears to provide the first study of osmium complexes in the zebrafish model, which has been shown to closely model toxicity in humans. A fluorescent osmium complex, derived from a lead compound, was employed to confirm internalization of the complex, visualize in vivo distribution, and confirm colocalization with reactive oxygen species generated in zebrafish.</description><subject>Antineoplastic Agents - chemistry</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Cell Line, Tumor</subject><subject>Cell Proliferation - drug effects</subject><subject>Drug Resistance, Neoplasm - drug effects</subject><subject>Drug Screening Assays, Antitumor</subject><subject>Humans</subject><subject>Organometallic Compounds - chemistry</subject><subject>Organometallic Compounds - pharmacology</subject><subject>Osmium - chemistry</subject><subject>Platinum - pharmacology</subject><subject>Reactive Oxygen Species - metabolism</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU9vEzEQxS1ERUPhGyDkYzlsGNv794JURRQiRUqVFK6W1zvbuNq1w9obNf0YfGKcJq3gwmkO83tvRu8R8oHBlAFnn5X20_seG73BflrWAFVWviITlnFI0hLS12QCwHnCcy7OyVvv7wFAMC7ekHMBXEDJiwn5Pbf0p9k5usYOdTA7E_ZU2YYunFadeVTBOEtdS1eoDmuky4f9HVq63qI26Onlarn-ROe2GfUTWu_p0vdm7OmVDUYrq3GgM9dvO3yI-O1GBTozgx77HdpAb7p4wUZ6hd74cMDfkbNWdR7fn-YF-XH99Xb2PVksv81nV4tEpWkVkryAEplIMyig1oUAbNschFaVEDpVoBtV1qJooaoyhrpVTSZaVtR5VpQ51iAuyJej73asDznGdwbVye1gejXspVNG_ruxZiPv3E7mHNIcWDS4PBkM7teIPsjeeI1dpyy60UvOWF6mBS_ziKZHVA_O-wHblzMM5KFOGeuUz3XKU51R9vHvF19Ez_1FAI7Ak9yNg42J_d_zD1mbsrs</recordid><startdate>20181025</startdate><enddate>20181025</enddate><creator>Coverdale, James P. C</creator><creator>Bridgewater, Hannah E</creator><creator>Song, Ji-Inn</creator><creator>Smith, Nichola A</creator><creator>Barry, Nicolas P. E</creator><creator>Bagley, Ian</creator><creator>Sadler, Peter J</creator><creator>Romero-Canelón, Isolda</creator><general>American Chemical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-9160-1941</orcidid><orcidid>https://orcid.org/0000-0003-3847-4626</orcidid><orcidid>https://orcid.org/0000-0002-7779-6620</orcidid><orcidid>https://orcid.org/0000-0002-0388-6295</orcidid></search><sort><creationdate>20181025</creationdate><title>In Vivo Selectivity and Localization of Reactive Oxygen Species (ROS) Induction by Osmium Anticancer Complexes That Circumvent Platinum Resistance</title><author>Coverdale, James P. C ; Bridgewater, Hannah E ; Song, Ji-Inn ; Smith, Nichola A ; Barry, Nicolas P. E ; Bagley, Ian ; Sadler, Peter J ; Romero-Canelón, Isolda</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a449t-6708e1345070bc730eff603ca933c4a0cda8b37f09951ecfad53f17b65786eb03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Antineoplastic Agents - chemistry</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Cell Line, Tumor</topic><topic>Cell Proliferation - drug effects</topic><topic>Drug Resistance, Neoplasm - drug effects</topic><topic>Drug Screening Assays, Antitumor</topic><topic>Humans</topic><topic>Organometallic Compounds - chemistry</topic><topic>Organometallic Compounds - pharmacology</topic><topic>Osmium - chemistry</topic><topic>Platinum - pharmacology</topic><topic>Reactive Oxygen Species - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Coverdale, James P. C</creatorcontrib><creatorcontrib>Bridgewater, Hannah E</creatorcontrib><creatorcontrib>Song, Ji-Inn</creatorcontrib><creatorcontrib>Smith, Nichola A</creatorcontrib><creatorcontrib>Barry, Nicolas P. E</creatorcontrib><creatorcontrib>Bagley, Ian</creatorcontrib><creatorcontrib>Sadler, Peter J</creatorcontrib><creatorcontrib>Romero-Canelón, Isolda</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Coverdale, James P. C</au><au>Bridgewater, Hannah E</au><au>Song, Ji-Inn</au><au>Smith, Nichola A</au><au>Barry, Nicolas P. E</au><au>Bagley, Ian</au><au>Sadler, Peter J</au><au>Romero-Canelón, Isolda</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In Vivo Selectivity and Localization of Reactive Oxygen Species (ROS) Induction by Osmium Anticancer Complexes That Circumvent Platinum Resistance</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>2018-10-25</date><risdate>2018</risdate><volume>61</volume><issue>20</issue><spage>9246</spage><epage>9255</epage><pages>9246-9255</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><abstract>Platinum drugs are widely used for cancer treatment. Other precious metals are promising, but their clinical progress depends on achieving different mechanisms of action to overcome Pt-resistance. Here, we evaluate 13 organo-Os complexes: 16-electron sulfonyl-diamine catalysts [(η6-arene)Os(N,N′)], and 18-electron phenylazopyridine complexes [(η6-arene)Os(N,N’)Cl/I]+ (arene = p-cymene, biphenyl, or terphenyl). Their antiproliferative activity does not depend on p21 or p53 status, unlike cisplatin, and their selective potency toward cancer cells involves the generation of reactive oxygen species. Evidence of such a mechanism of action has been found both in vitro and in vivo. This work appears to provide the first study of osmium complexes in the zebrafish model, which has been shown to closely model toxicity in humans. A fluorescent osmium complex, derived from a lead compound, was employed to confirm internalization of the complex, visualize in vivo distribution, and confirm colocalization with reactive oxygen species generated in zebrafish.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>30230827</pmid><doi>10.1021/acs.jmedchem.8b00958</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0001-9160-1941</orcidid><orcidid>https://orcid.org/0000-0003-3847-4626</orcidid><orcidid>https://orcid.org/0000-0002-7779-6620</orcidid><orcidid>https://orcid.org/0000-0002-0388-6295</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-2623 |
ispartof | Journal of medicinal chemistry, 2018-10, Vol.61 (20), p.9246-9255 |
issn | 0022-2623 1520-4804 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6204601 |
source | MEDLINE; American Chemical Society Journals |
subjects | Antineoplastic Agents - chemistry Antineoplastic Agents - pharmacology Cell Line, Tumor Cell Proliferation - drug effects Drug Resistance, Neoplasm - drug effects Drug Screening Assays, Antitumor Humans Organometallic Compounds - chemistry Organometallic Compounds - pharmacology Osmium - chemistry Platinum - pharmacology Reactive Oxygen Species - metabolism |
title | In Vivo Selectivity and Localization of Reactive Oxygen Species (ROS) Induction by Osmium Anticancer Complexes That Circumvent Platinum Resistance |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T05%3A15%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In%20Vivo%20Selectivity%20and%20Localization%20of%20Reactive%20Oxygen%20Species%20(ROS)%20Induction%20by%20Osmium%20Anticancer%20Complexes%20That%20Circumvent%20Platinum%20Resistance&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Coverdale,%20James%20P.%20C&rft.date=2018-10-25&rft.volume=61&rft.issue=20&rft.spage=9246&rft.epage=9255&rft.pages=9246-9255&rft.issn=0022-2623&rft.eissn=1520-4804&rft_id=info:doi/10.1021/acs.jmedchem.8b00958&rft_dat=%3Cproquest_pubme%3E2116847286%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2116847286&rft_id=info:pmid/30230827&rfr_iscdi=true |